Latch AI Inc.

Latch AI Inc. develops innovative biological solutions aimed at addressing environmental and health-related challenges through advanced biotechnology. Their focus is on enhancing agricultural efficiency and food production. Latch AI Inc.

was founded in 2021 and is headquartered in San Francisco, US. The company specializes in biotechnological solutions and has undergone no significant pivots in its business strategy. The founders of the company are Alfredo Andere, Kenny Workman, and Kyle Giffin, with Alfredo Andere also serving as the CEO. Latch AI Inc.

has completed two funding rounds, the most recent being a Series A round on June 2, 2022, where they raised USD 28. 00 mn from investors including Caffeinated Capital, Coatue Management, Fifty Years, Haystack, Hummingbird Ventures, and Lux Capital. The total amount raised by the company stands at USD 28. 00 mn, with a current valuation of USD 132.

69 mn. Latch AI Inc. specializes in innovative biological solutions designed to address a range of environmental and health-related challenges. The company's core product offerings include advanced biotechnological tools aimed at improving agricultural efficiency and enhancing food production.

These products are utilized by various sectors, including agriculture, biotechnology, and research institutions, positioning Latch AI as a critical player in promoting sustainable practices. Their technology is engineered to optimize crop yield and resilience, targeting markets in North America, Europe, and parts of Asia, where agricultural productivity faces increasing demands from a growing population. End users include farmers, agricultural cooperatives, and research scientists, all seeking to leverage Latch AI's solutions to ensure food security and ecological sustainability. Latch AI Inc.

operates under a structured revenue model primarily based on B2B transactions, collaborating directly with agricultural and biotechnology firms. The company generates revenue through a combination of product sales, subscription-based access to its proprietary technology platforms, and strategic partnerships with research institutions. Flagship products include trademarked biotechnological solutions that facilitate improved agricultural outcomes. Pricing structures are established according to the specific needs of clients, which can include tiered subscription plans for access to software tools and premium pricing for specialized biotechnological products.

This transactional framework allows Latch AI to effectively cater to diverse customer requirements while fostering long-term relationships in the industries it serves. In June 2022, Latch AI Inc. raised USD 28. 00 mn in Series A funding, co-led by Coatue Management and Lux Capital, with participation from Hummingbird Ventures, Caffeinated Capital, Haystack, and Fifty Years.

The company plans to utilize this funding to develop a web-based platform that enables researchers to store and analyze data. Latch AI is also looking to expand its presence in new markets, targeting regions in Asia and Europe for future growth.